Kymera Therapeutics Inc. (KYMR)
44.15
0.02 (0.05%)
At close: Jan 23, 2025, 3:59 PM
44.23
0.18%
After-hours Jan 23, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -10.11 | -8.87 | -31.09 | -24.48 | -35.87 | -68.99 |
| PS Ratio | 18.91 | 28.75 | 41.83 | 31.61 | 504.79 | n/a |
| PB Ratio | 3.76 | 2.75 | 6.63 | 3.79 | -19.91 | -43.01 |
| P/FCF Ratio | -10.82 | -8.63 | -23.34 | 13.61 | 85.25 | -77.06 |
| P/OCF Ratio | -14.45 | -8.79 | -23.63 | 12.21 | 82.72 | -82.91 |
| OCF/S Ratio | -1.31 | -3.27 | -1.77 | 2.59 | 6.10 | n/a |
| Debt / Equity Ratio | 0.21 | 0.04 | 0.04 | 0.06 | -0.28 | -0.02 |
| Quick Ratio | 4.73 | 9.04 | 5.71 | 4.21 | 2.69 | 8.92 |
| Current Ratio | 4.73 | 8.84 | 5.62 | 2.73 | 2.69 | 8.92 |
| Asset Turnover | 0.14 | 0.08 | 0.12 | 0.07 | 0.03 | n/a |
| Interest Coverage | -844.54 | -916.23 | -574.46 | -402.64 | -917.5 | -1.34K |
| Return on Equity (ROE) | -0.37 | -0.31 | -0.21 | -0.15 | 0.55 | 0.62 |
| Return on Assets (ROA) | -0.26 | -0.25 | -0.16 | -0.09 | -0.35 | -0.49 |
| Return on Capital (ROIC) | -0.34 | -0.3 | -0.2 | -0.12 | -0.51 | -0.54 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -140.59% | 93.64% | 96.71% | -82.48% | 71.88% | n/a |
| Net Profit Margin | -186.99% | -324.25% | -134.55% | -129.12% | -1.41K% | n/a |
| Pretax Profit Margin | -186.99% | -330.6% | -137.6% | -133.96% | -1.41K% | n/a |
| Operating Profit Margin | -210.62% | -344.37% | -138.03% | -136.05% | -1.44K% | n/a |
| FCF Margin | -174.71% | -332.98% | -179.24% | 232.22% | 592.13% | n/a |
| EBITDA Margin | -182.21% | -323.87% | -134.07% | -128.45% | -1.38K% | n/a |